CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma

(2016) Chaoya Ma et al.   CANCER SCIENCE

Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma

(2016) Yong Hu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences

(2014) P Balermpas et al.   BRITISH JOURNAL OF CANCER

Expression of Tumor-Associated Macrophage in Progression of Human Glioma

(2014) Peng Ding et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas

(2014) Motokazu Sugimoto et al.   EUROPEAN JOURNAL OF CANCER

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

(2014) Robert S. Svatek et al.   EUROPEAN UROLOGY

Macrophage Regulation of Tumor Responses to Anticancer Therapies

(2013) Michele De Palma et al.   CANCER CELL

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

(2013) G Comito et al.   ONCOGENE

Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer

(2013) Chunyan Lan et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

(2012) Niels Fristrup et al.   AMERICAN JOURNAL OF PATHOLOGY

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer

(2012) Bas W.G. van Rhijn et al.   BJU INTERNATIONAL

Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

(2011) Tahlita C.M. Zuiverloon et al.   EUROPEAN UROLOGY

Systematic validation of specific phenotypic markers for in vitro polarized human macrophages

(2011) C.A. Ambarus et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis

(2011) Daniel Canter et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Macrophage Diversity Enhances Tumor Progression and Metastasis

(2010) Bin-Zhi Qian et al.   CELL

Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications

(2009) Matthias May et al.   EUROPEAN UROLOGY

An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer

(2009) Girish S. Kulkarni et al.   EUROPEAN UROLOGY

Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time

(2009) Ivan Shabo et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic versus predictive value of biomarkers in oncology

(2008) C.N.A.M. Oldenhuis et al.   EUROPEAN JOURNAL OF CANCER

Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?

(2007) Stefan Denzinger et al.   EUROPEAN UROLOGY